- Home
- NEGG vs NYXH Comparison
NEGG vs NYXH Comparison
Compare NEGG & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- NYXH
- Stock Information
- Founded
- NEGG 2001
- NYXH 2009
- Country
- NEGG United States
- NYXH Belgium
- Employees
- NEGG N/A
- NYXH N/A
- Industry
- NEGG Other Specialty Stores
- NYXH Medical/Dental Instruments
- Sector
- NEGG Consumer Discretionary
- NYXH Health Care
- Exchange
- NEGG Nasdaq
- NYXH Nasdaq
- Market Cap
- NEGG 293.6M
- NYXH 261.1M
- IPO Year
- NEGG 2010
- NYXH 2021
- Fundamental
- Price
- NEGG $0.65
- NYXH $9.54
- Analyst Decision
- NEGG
- NYXH Strong Buy
- Analyst Count
- NEGG 0
- NYXH 5
- Target Price
- NEGG N/A
- NYXH $17.00
- AVG Volume (30 Days)
- NEGG 335.7K
- NYXH 171.0K
- Earning Date
- NEGG 10-25-2024
- NYXH 11-06-2024
- Dividend Yield
- NEGG N/A
- NYXH N/A
- EPS Growth
- NEGG N/A
- NYXH N/A
- EPS
- NEGG N/A
- NYXH N/A
- Revenue
- NEGG $1,391,833,000.00
- NYXH $5,134,469.00
- Revenue This Year
- NEGG $6.01
- NYXH $49.72
- Revenue Next Year
- NEGG N/A
- NYXH $395.59
- P/E Ratio
- NEGG N/A
- NYXH N/A
- Revenue Growth
- NEGG N/A
- NYXH 57.79
- 52 Week Low
- NEGG $0.52
- NYXH $4.00
- 52 Week High
- NEGG $2.15
- NYXH $20.00
- Technical
- Relative Strength Index (RSI)
- NEGG 32.74
- NYXH 63.88
- Support Level
- NEGG $0.67
- NYXH $9.23
- Resistance Level
- NEGG $0.72
- NYXH $10.12
- Average True Range (ATR)
- NEGG 0.04
- NYXH 0.50
- MACD
- NEGG -0.00
- NYXH -0.00
- Stochastic Oscillator
- NEGG 0.08
- NYXH 64.20
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.